To The Moon

$Smith And Wesson Brands Inc(SWBI)$

Smith & Wesson is a fascinating company—it’s a firearms manufacturer that primarily sells to consumers. It remains relatively small, with a market cap of less than half a billion dollars. The stock is highly volatile, fluctuating between $30 and $6 over the past five years. However, it offers a solid dividend yield and has consistently repurchased shares.

Is Smith & Wesson Stock a Buy?

Before making an investment decision, it's crucial to understand the nature of the company. Smith & Wesson generates revenue mainly from two product categories: handguns and long guns. While they offer some additional products and services, the bulk of their income comes from handguns, which is what they’re best known for—particularly their revolvers.

The challenge is that firearms aren’t recurring purchases. Even in the U.S., most consumers don’t buy handguns regularly. As a result, Smith & Wesson’s revenue is highly volatile. Looking at quarterly reports, their sales tend to fluctuate based on external factors like political uncertainty or concerns about potential regulations. The company saw strong growth until 2016, but revenue has since plateaued.

For example, during periods of heightened demand—such as the COVID-19 pandemic—sales soared, and Smith & Wesson earned $300 million in just 12 months, nearly matching its entire market cap. But in slower periods, profits drop significantly—sometimes to as little as $6 million. Currently, they are in a middle ground, with $30 million in earnings.

The Problem with Smith & Wesson’s Business Model

One key drawback is the lack of recurring revenue. Unlike other businesses that benefit from ongoing customer spending, Smith & Wesson relies on sporadic firearm purchases. Some might assume that ammunition sales could provide a steady income stream, but the company sold off its ammunition business long ago due to low profitability. While firearm prices have generally kept up with inflation, ammunition prices have declined as production methods improved.

The Myth of a Return to Growth

It’s tempting to assume that Smith & Wesson will return to its pre-2017 growth trajectory. However, a closer look reveals that much of their past expansion came from acquisitions rather than organic growth. Between 2010 and 2017, the company heavily diluted shares to fund multiple $100 million acquisitions. Since then, that strategy has changed, and the business is no longer growing in the same way.

In conclusion, while Smith & Wesson has its strengths—such as shareholder-friendly policies like buybacks and dividends—its volatile revenue, lack of recurring sales, and reliance on external factors make it a risky investment.

Smith & Wesson has not pursued acquisitions in recent years, and its growth has plateaued. Additionally, its profit margins have normalized. One perspective is that the company is currently at a low point in its business cycle—fewer people are purchasing handguns at the moment, but demand could increase in the future if economic or political conditions change.

However, with Donald Trump as president, I don’t see a surge in gun sales happening anytime soon. Gun owners often buy firearms when they fear potential restrictions. For example, after high-profile events like school shootings, firearm sales tend to spike due to concerns over increased regulation. While Trump has enacted some firearm restrictions in the past, he is generally not perceived as an anti-gun politician. As a result, there isn’t much urgency among consumers to stock up on handguns right now. The market seems to reflect this sentiment, as the stock is trading near its low.

Valuation and Market Cycles

Some may argue that Smith & Wesson’s current valuation presents an opportunity. The stock’s forward P/E ratio is around 23, which isn’t particularly cheap. However, since this is a cyclical business, a return to historical earnings—such as the $100 million seen in 2016—would push the P/E down to below 5. If this is indeed a low point in the cycle, it could be a good time to buy.

Potential Risks and Advantages

Regulatory changes could disrupt the cycle, but Smith & Wesson has an advantage here. Gun control measures tend to focus on assault rifles rather than handguns, which are the company’s primary revenue source. Additionally, the company has a relatively low debt burden. While it has taken on some debt recently to support share buybacks and dividend payments, much of its reported long-term debt ($133 million) consists of leases rather than traditional liabilities. With $39 million in cash on hand and minimal goodwill ($21 million), the risk of bankruptcy is low.

Shareholder Returns

Smith & Wesson has a history of shareholder-friendly policies. During downturns, dilution is minimal (around 1–2%), and when times are good, the company aggressively repurchases shares due to its strong free cash flow—averaging about 3% in annual buybacks. The current dividend yield stands at 5%, and while a dividend cut is possible if cash flow remains weak, the company would likely reduce buybacks before cutting payouts.

Future Outlook

Smith & Wesson has invested heavily in production, which could position it for future growth once demand picks up. If the company emerges from this investment phase with stronger operational efficiency, it could provide significant upside for investors. I believe that once shipments increase again, Smith & Wesson has the potential to generate substantial cash flow.

Valuation & Expected Returns

To determine a fair price for the stock, I’d look at normalized free cash flow. Historically, free cash flow cycles between $40 million in weak periods and $100 million in strong ones. A reasonable midpoint estimate would be $75 million.

At that level, free cash flow per share comes to approximately $1.66. Assuming the company distributes 33% of its cash flow as dividends (with a slight deduction for taxes) and continues buying back 3–4% of shares annually, Smith & Wesson’s growth would likely track inflation, around 3%. Given the slow growth of the gun market, significant expansion is unlikely, though an occasional hit product could boost revenue.

For cyclical stocks like this—especially those reliant on individual purchases—high valuation multiples are uncommon. A conservative 10x multiple seems appropriate. Based on this, the fair value of the stock would be around $14 per share, compared to its current price of $10.70—indicating a potential 34% upside at a 10% return, which is not bad.

Risks & Uncertainties

However, this valuation depends heavily on the assumption that free cash flow will average $75 million over time. If that number falls to $50 million, free cash flow per share drops to $1.11, significantly reducing expected returns. The gun market is less predictable than other cyclical industries like mining, where prices tend to rebound over time. In contrast, U.S. firearm demand could remain depressed for an extended period, limiting buybacks and dividends.

That said, if the market improves and demand for guns rises—driving earnings beyond $75 million—valuations could expand slightly (to an 8–9x multiple), and the stock could potentially double. On the downside, if growth remains stagnant and Smith & Wesson trades at a lower 7x multiple, fair value would be around $9 per share—not a drastic drop from current levels.

Acquisition Potential

One factor worth noting is Smith & Wesson’s relatively small market cap of $470 million, making it an attractive acquisition target. A company looking to enter the consumer firearms market could easily offer $1 billion—roughly twice its current valuation—which the board would likely accept. While I’m not banking on an acquisition, it’s a possibility that could provide investors with a quick return.

Conclusion

Overall, I don’t see Smith & Wesson as a particularly risky investment at this price, given its relatively low downside. However, the reward potential also isn’t extraordinary. There are likely better opportunities in the market with stronger business models. That said, firearm demand can shift rapidly, and if Smith & Wesson’s net income jumps from $36 million to $100 million, the stock will almost certainly not remain below a 5x P/E ratio.

What do you think? Let me know in the comments. Have a great day!

@Daily_Discussion @TigerPM @TigerObserver @Tiger_comments @TigerClub

Disclaimer: I want to make it clear that I am not a financial advisor, and nothing I say is intended to be a recommendation to buy or sell any financial instrument. Additionally, it's important to remember that there are no guarantees or certainties in trading or investing, and you should never invest money that you can't afford to lose.